Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1727-1729

  Shearer, Michael H ^b   Timanus, Dusti K ^b   Benton, Patricia A ^b   Lee, D Rick ^b   Kennedy, Ronald C ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; OKT 4; PHYTOHEMAGGLUTININ; TETRAMETHYLBENZIDINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

EID: 0031779312     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517432     Document Type: Article

References (11)

1. Mascola JR, Louwagie J, McCutchan FE, et al. Two antigenically distinct subtypes of HIV-1: viral genotype predicts neutralization serotype. J Infect Dis 1994;169:48-54.
2. Hanson CV. Measuring vaccine-induced HIV neutralization: report of a workshop. AIDS Res Hum Retroviruses 1994;10:645-8.
3. Matthews TJ. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res Hum Retroviruses 1994;10: 631-2.
4. Cohen J. Jitters jeopardize AIDS vaccine trials. Science 1993;262: 980-1.
5. Dostrikis LG, Bagldades E, Cao Y, Zhand L, Dimitriou D, Ho DD. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol 1995;69:6122-30.
6. Moore JP, Cao Y, Leu J, Qin L, Korber B, Ho DD. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol 1996;70:427-44.
7. Attanasio R, Allan JS, Kennedy RC. Monoclonal anti-CD4 as immunoprophylactic agents for human immunodeficiency virus infection. J Infect Dis 1993;168:515-6.
8. Kieber-Emmons T, Janeson B, Morrow W. The gp120/CD4 interface; structural, immunological, and pathological considerations. Biochim Biophys Acta 1989;989:281-300.
9. Wilks D, Walker LC, Habeshaw JA, Webster ADB, Dalgleish AG. Antiidiotypic responses to immunization with anti-Leu 3a in human immunodeficiency virus-seropositive individuals. J Infect Dis 1991;163: 389-92.
10. Knox S, Levy R, Hodgkinson S, et al. Observations of the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Blood 1991;77:20-30.
11. Lohman KL, Attanasio R, Buck DW, et al. Characteristics of murine monoclonal anti-CD4: epitope recognition, idiotype expression, and variable region gene sequence. Immunology 1992;149:3247-53.